Literature DB >> 20443038

Myotonic dystrophy type I combined with X-linked dominant Charcot-Marie-Tooth neuropathy.

Hyun Sook Kim1, Ki Wha Chung, Sung Hee Kang, Sung Kyung Choi, Sun Young Cho, Heasoo Koo, Sang-Beom Kim, Byung-Ok Choi.   

Abstract

Both the myotonic dystrophy type 1 (DM1) and the X-linked dominant Charcot-Marie-Tooth disease (CMTX1) are well-established inherited neuromuscular disorders characterized by progressive weakness and atrophy of the distal limb muscles. The underlying causes of the DM1 and CMTX1 are mutations in the DMPK and GJB1 gene, respectively. A patient with both DM1 and CMTX1 inherited these from his father and mother, respectively. Histopathological and electrodiagnostic studies revealed both chronic neuropathic and myopathic features. Physical disabilities were more severe than seen with either DM1 or CMTX1 alone. In addition, the present case reveals an asymmetric atrophy (22%) of the right calf muscle compared to the left side.

Entities:  

Mesh:

Year:  2010        PMID: 20443038     DOI: 10.1007/s10048-010-0246-5

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  24 in total

1.  Peripheral neuropathy in myotonic dystrophy: a nerve biopsy study.

Authors:  D Cros; P Harnden; J Pouget; J F Pellissier; J L Gastaut; G Serratrice
Journal:  Ann Neurol       Date:  1988-05       Impact factor: 10.422

2.  Axonal motor and sensory neuropathy in myotonic dystrophy.

Authors:  M Mondelli; A Rossi; A Malandrini; P Della Porta; G C Guzaai
Journal:  Acta Neurol Scand       Date:  1993-08       Impact factor: 3.209

3.  250 CTG repeats in DMPK is a threshold for correlation of expansion size and age at onset of juvenile-adult DM1.

Authors:  Dusanka Savić; Vidosava Rakocvic-Stojanovic; Dusan Keckarevic; Biljana Culjkovic; Oliver Stojkovic; Jelena Mladenovic; Slobodanka Todorovic; Slobodan Apostolski; Stanka Romac
Journal:  Hum Mutat       Date:  2002-02       Impact factor: 4.878

4.  Assessment of a disease-specific muscular impairment rating scale in myotonic dystrophy.

Authors:  J Mathieu; H Boivin; D Meunier; M Gaudreault; P Bégin
Journal:  Neurology       Date:  2001-02-13       Impact factor: 9.910

5.  Compound Charcot-Marie-Tooth disease may determine unusual and milder phenotypes.

Authors:  Silmara P Gouvea; Vinícius H S Borghetti; Keity C Bueno; Adriana B Genari; Charles M Lourenço; Claudia Sobreira; Amilton A Barreira; Wilson Marques
Journal:  Neurogenetics       Date:  2009-08-25       Impact factor: 2.660

Review 6.  Connexin32 and X-linked Charcot-Marie-Tooth disease.

Authors:  L J Bone; S M Deschênes; R J Balice-Gordon; K H Fischbeck; S S Scherer
Journal:  Neurobiol Dis       Date:  1997       Impact factor: 5.996

7.  Combination of myotonic dystrophy and hereditary motor and sensory neuropathy.

Authors:  Semiha Kurt; Hatice Karaer; Yuksel Kaplan; Irem Akat; Esra Battaloglu; Didem Eruslu; A Nazli Basak
Journal:  J Neurol Sci       Date:  2009-10-21       Impact factor: 3.181

8.  Different clinical and magnetic resonance imaging features between Charcot-Marie-Tooth disease type 1A and 2A.

Authors:  K W Chung; B C Suh; M E Shy; S Y Cho; J H Yoo; S W Park; H Moon; K D Park; K G Choi; S Kim; S B Kim; D S Shim; S M Kim; I N Sunwoo; B O Choi
Journal:  Neuromuscul Disord       Date:  2008-07-07       Impact factor: 4.296

Review 9.  Myotonic dystrophy: RNA pathogenesis comes into focus.

Authors:  Laura P W Ranum; John W Day
Journal:  Am J Hum Genet       Date:  2004-04-02       Impact factor: 11.025

10.  Epidemiology of myotonic dystrophy in Italy: re-apprisal after genetic diagnosis.

Authors:  G Siciliano; M Manca; M Gennarelli; C Angelini; A Rocchi; A Iudice; M Miorin; M Mostacciuolo
Journal:  Clin Genet       Date:  2001-05       Impact factor: 4.438

View more
  7 in total

1.  A complex phenotype of peripheral neuropathy, myopathy, hoarseness, and hearing loss is linked to an autosomal dominant mutation in MYH14.

Authors:  Byung-Ok Choi; Sung Hee Kang; Young Se Hyun; Sumaria Kanwal; Sun Wha Park; Heasoo Koo; Sang-Beom Kim; Young-Chul Choi; Jeong Hyun Yoo; Jong-Won Kim; Kee Duk Park; Kyoung-Gyu Choi; Song Ja Kim; Stephan Züchner; Ki Wha Chung
Journal:  Hum Mutat       Date:  2011-04-07       Impact factor: 4.878

Review 2.  Intermediate Charcot-Marie-Tooth disease: an electrophysiological reappraisal and systematic review.

Authors:  José Berciano; Antonio García; Elena Gallardo; Kristien Peeters; Ana L Pelayo-Negro; Silvia Álvarez-Paradelo; José Gazulla; Miriam Martínez-Tames; Jon Infante; Albena Jordanova
Journal:  J Neurol       Date:  2017-03-31       Impact factor: 4.849

3.  Co-segregation of a homozygous SMN1 deletion and a heterozygous PMP22 duplication in a patient.

Authors:  Raquel M Fernández; Ana Peciña; Beatriz Muñoz-Cabello; Guillermo Antiñolo; Salud Borrego
Journal:  Clin Case Rep       Date:  2016-08-09

4.  Coexistent Charcot-Marie-Tooth type 1A and type 2 diabetes mellitus neuropathies in a Chinese family.

Authors:  A-Ping Sun; Lu Tang; Qin Liao; Hui Zhang; Ying-Shuang Zhang; Jun Zhang
Journal:  Neural Regen Res       Date:  2015-10       Impact factor: 5.135

5.  Whole exome sequencing establishes diagnosis of Charcot-Marie-Tooth 4J, 1C, and X1 subtypes.

Authors:  Kleita Michaelidou; Ioannis Tsiverdis; Sophia Erimaki; Dimitra Papadimitriou; Georgios Amoiridis; Alexandros Papadimitriou; Panayiotis Mitsias; Ioannis Zaganas
Journal:  Mol Genet Genomic Med       Date:  2020-02-05       Impact factor: 2.183

6.  Genetic Spectrum of Inherited Neuropathies in India.

Authors:  Shivani Sharma; Periyasamy Govindaraj; Yasha T Chickabasaviah; Ramesh Siram; Akhilesh Shroti; Doniparthi V Seshagiri; Monojit Debnath; Parayil S Bindu; Arun B Taly; Madhu Nagappa
Journal:  Ann Indian Acad Neurol       Date:  2022-06-14       Impact factor: 1.714

7.  Intergenerational Influence of Gender and the DM1 Phenotype of the Transmitting Parent in Korean Myotonic Dystrophy Type 1.

Authors:  Ji Yoon Han; Woori Jang; Joonhong Park
Journal:  Genes (Basel)       Date:  2022-08-17       Impact factor: 4.141

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.